RFK Filings Show Biopharma Stakes, Millions In Firm Income <https://www.law360.com/health/articles/2287526?nl_pk=0f5983ea-0173-4e74-85e2-7daeb9cfc0fc&utm_source=newsletter&utm_medium=email&utm_campaign=health&utm_content=2025-01-23&read_main=1&nlsidx=0&nlaidx=0>
By Yeji Jesse Lee Robert F. Kennedy Jr. plans to sell off his stakes in two biopharmaceutical companies and step back from lucrative roles at a handful of law firms if he is confirmed to lead the U.S. Department of Health and Human Services, according to new financial disclosures. 2 documents attached | Read full article » <https://www.law360.com/health/articles/2287526?nl_pk=0f5983ea-0173-4e74-85e2-7daeb9cfc0fc&utm_source=newsletter&utm_medium=email&utm_campaign=health&utm_content=2025-01-23&read_more=1&nlsidx=0&nlaidx=0> | Save to favorites » <https://www.law360.com/health/articles/2287526?nl_pk=0f5983ea-0173-4e74-85e2-7daeb9cfc0fc&utm_source=newsletter&utm_medium=email&utm_campaign=health&utm_content=2025-01-23&read_later=1&nlsidx=0&nlaidx=0>
